Homocysteine metabolism in cardiovascular cells and tissues: implications for hyperhomocysteinemia and cardiovascular disease.
暂无分享,去创建一个
R. Green | K. Robinson | D. Jacobsen | P. Dibello | W. Kruger | T. Garrow | E. Tipa | P. Chen | R. Poddar | C. Moravec | P. Chen | Killian Robinson | Christine S. Moravec | Killian Robinson | Ralph Green | Warren D. Kruger | Donald W. Jacobsen
[1] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[2] D. Jacobsen. Homocysteine and vitamins in cardiovascular disease. , 1998, Clinical chemistry.
[3] E. Tuzcu,et al. High homocysteine, low folate, and low vitamin B6 concentrations: prevalent risk factors for vascular disease in heart transplant recipients. , 1998, Transplantation.
[4] J. Witteman,et al. Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group. , 1998, Circulation.
[5] Č. Vlček,et al. Identification and tissue distribution of human cystathionine beta-synthase mRNA isoforms. , 1998, Archives of biochemistry and biophysics.
[6] S. Sunden,et al. Betaine-homocysteine methyltransferase expression in porcine and human tissues and chromosomal localization of the human gene. , 1997, Archives of biochemistry and biophysics.
[7] M. Manning,et al. Secondary structure of recombinant human cystathionine beta-synthase in aqueous solution: effect of ligand binding and proteolytic truncation. , 1997, Archives of biochemistry and biophysics.
[8] A. Bostom,et al. Hyperhomocysteinemia in end-stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes. , 1997, Kidney international.
[9] J. Witteman,et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. , 1997, JAMA.
[10] M. Kutner,et al. Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations. , 1996, Circulation.
[11] T. Garrow. Purification, Kinetic Properties, and cDNA Cloning of Mammalian Betaine-Homocysteine Methyltransferase* , 1996, The Journal of Biological Chemistry.
[12] S. Vollset,et al. Homocysteine and Cardiovascular Disease , 1996, The Journal of the American Board of Family Medicine.
[13] K. Robinson,et al. Homocysteine and coronary atherosclerosis. , 1996, Journal of the American College of Cardiology.
[14] R. Paroni,et al. Prevalence of Moderate Hyperhomocysteinemia in Patients with Early-Onset Venous and Arterial Occlusive Disease , 1995, Annals of Internal Medicine.
[15] David P Miller,et al. Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease. , 1995, Circulation.
[16] G. Omenn,et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. , 1995, JAMA.
[17] P. Kamoun,et al. Genomic organization of the human cystathionine beta-synthase gene: evidence for various cDNAs. , 1995, Biochemical and biophysical research communications.
[18] R. Rodeheffer,et al. Increase in total plasma homocysteine concentration after cardiac transplantation. , 1995, Mayo Clinic proceedings.
[19] J. Kraus,et al. Transsulfuration depends on heme in addition to pyridoxal 5'-phosphate. Cystathionine beta-synthase is a heme protein. , 1994, The Journal of biological chemistry.
[20] J. Kraus,et al. Expression of human cystathionine beta-synthase in Escherichia coli: purification and characterization. , 1994, Protein expression and purification.
[21] M. Swaroop,et al. Human cystathionine beta-synthase cDNA: sequence, alternative splicing and expression in cultured cells. , 1993, Human molecular genetics.
[22] L. Chambless,et al. Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study. , 1993, Circulation.
[23] D. Wilcken,et al. Homocysteine catabolism: levels of 3 enzymes in cultured human vascular endothelium and their relevance to vascular disease. , 1992, Atherosclerosis.
[24] M. Swaroop,et al. Rat cystathionine beta-synthase. Gene organization and alternative splicing. , 1992, The Journal of biological chemistry.
[25] B. Norrving,et al. Hyperhomocysteinaemia in stroke: prevalence, cause, and relationships to type of stroke and stroke risk factors , 1992, European journal of clinical investigation.
[26] D. Wilcken,et al. Betaine:homocysteine methyltransferase--a new assay for the liver enzyme and its absence from human skin fibroblasts and peripheral blood lymphocytes. , 1991, Clinica chimica acta; international journal of clinical chemistry.
[27] D. Weir,et al. Betaine-homocysteine methyltransferase: organ distribution in man, pig and rat and subcellular distribution in the rat. , 1991, Clinical science.
[28] J. Finkelstein,et al. Methionine metabolism in mammals. , 1990, The Journal of nutritional biochemistry.
[29] M. Malinow,et al. Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke. , 1990, Stroke.
[30] M. Malinow,et al. Homocyst(e)inemia in daily practice: levels in coronary artery disease , 1990 .
[31] J. Kraus,et al. Biosynthesis and proteolytic activation of cystathionine beta-synthase in rat liver. , 1984, The Journal of biological chemistry.
[32] J. Kraus,et al. Cystathionine beta-synthase from human liver: improved purification scheme and additional characterization of the enzyme in crude and pure form. , 1983, Archives of biochemistry and biophysics.
[33] A. Pick,et al. Activation of cystathionine synthase by adenosylmethionine and adenosylethionine. , 1975, Biochemical and biophysical research communications.
[34] J. Finkelstein,et al. Methionine metabolism in mammals: regulatory effects of S-adenosylhomocysteine. , 1974, Archives of biochemistry and biophysics.
[35] M. Seashore,et al. Studies of the Mechanism of Pyridoxine-Responsive Homocystinuria , 1972, Pediatric Research.
[36] S. Mudd,et al. Cystathionine Synthase in Tissue Culture Derived from Human Skin: Enzyme Defect in Homocystinuria , 1968, Science.
[37] J. Finkelstein,et al. Transsulfuration in mammals. Microassays and tissue distributions of three enzymes of the pathway. , 1965, The Journal of biological chemistry.
[38] J. Finkelstein,et al. Homocystinuria: An Enzymatic Defect , 1964, Science.
[39] T. Gerritsen,et al. The identification of homocystine in the urine. , 1962, Biochemical and biophysical research communications.
[40] D. W. Neill,et al. Metabolic Abnormalities Detected in a Survey of Mentally Backward Individuals in Northern Ireland , 1962, Archives of disease in childhood.
[41] L. W. Butz,et al. THE FORMATION OF A HOMOLOGUE OF CYSTINE BY THE DECOMPOSITION OF METHIONINE WITH SULFURIC ACID , 1932 .
[42] P. Sarkar,et al. Regulation of actin and tubulin gene expression by thyroid hormone during rat brain development. , 1996, Brain research. Molecular brain research.
[43] S. Mudd. Disorders of transsulfuration , 1989 .
[44] J. Kraus. Cystathionine β-synthase (human) , 1987 .
[45] D. Cox,et al. Structural and functional conservation of the human and yeast genes , 2022 .